Wunderlich Capital Managemnt’s GSK GSK Stock Holding History

Wunderlich Capital Managemnt’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-36,058	Closed	-$1.76M	–	92
2018 Q1	$1.76M	Buy	+36,058	New	+$1.68M	1.21%	29
2017 Q4	–	Sell	-27,207	Closed	-$1.38M	–	94
2017 Q3	$1.38M	Sell	27,207 -41	-0.2%	-$2.08K	1.03%	53
2017 Q2	$1.47M	Sell	27,248 -366	-1%	-$19.5K	1.1%	45
2017 Q1	$1.46M	Buy	27,614 +524	+2%	+$26.6K	1.14%	42
2016 Q4	$1.3M	Sell	27,090 -282	-1%	-$13.9K	1.06%	55
2016 Q3	$1.48M	Buy	27,372 +712	+3%	+$39K	1.18%	39
2016 Q2	$1.44M	Buy	26,660 +253	+1%	+$13.3K	1.22%	34
2016 Q1	$1.34M	Buy	26,407 +485	+2%	+$24.2K	1.15%	49
2015 Q4	$1.31M	Buy	+25,922	New	+$1.32M	1.12%	41

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Wunderlich Capital Managemnt's GSK Position: Q2 2018 in Review

Wunderlich Capital Managemnt sold out of GSK (GSK) in Q2 2018, closing a stake of 36,058 shares — an estimated $1.76M sold.

Wunderlich Capital Managemnt first reported a position in GSK in Q4 2015 and held it in 9 quarters. The position peaked at $1.76M in Q1 2018. 787 funds tracked by Wall St. Rank hold GSK as of Q2 2018.

Wunderlich Capital Managemnt reported no remaining GSK position as of Q2 2018 after selling out during the quarter.
Wunderlich Capital Managemnt sold 36,058 GSK shares in Q2 2018, an estimated $1.76M.
Wunderlich Capital Managemnt first reported a position in GSK in Q4 2015 and held it in 9 quarters.
Wunderlich Capital Managemnt's GSK position peaked at $1.76M in Q1 2018.
787 funds tracked by Wall St. Rank held GSK as of Q2 2018.

Based on Wunderlich Capital Managemnt's 13F filing for Q2 2018, filed 14 Aug 2018.